735 filings
SC 13G/A
JPM
JPMorgan Chase & Co.
9 Dec 20
TherapeuticsMD / JPMORGAN CHASE & CO ownership change
11:54am
4
Donegan Michael C
27 Nov 20
TherapeuticsMD / Michael C Donegan ownership change
5:09pm
4
Milligan John C.K. IV
27 Nov 20
TherapeuticsMD / John C.K. IV Milligan ownership change
5:05pm
4
Finizio Robert G
27 Nov 20
TherapeuticsMD / Robert G Finizio ownership change
5:01pm
424B5
TXMD
TherapeuticsMD Inc
27 Nov 20
Prospectus supplement for primary offering
4:46pm
8-K
3ib4 xwj8hu6s8n9j
27 Nov 20
Entry into a Material Definitive Agreement
4:35pm
8-K
knjylbo
13 Nov 20
Entry into a Material Definitive Agreement
12:00am
424B2
f7t2ah
12 Nov 20
Prospectus for primary offering
5:18pm
424B5
7wus1l
9 Nov 20
Prospectus supplement for primary offering
5:27pm
8-K
4xlv238
9 Nov 20
TherapeuticsMD® Announces Third Quarter 2020 Financial Results
6:55am
8-K
x8pm1718uzvcy7 a5
14 Sep 20
Regulation FD Disclosure
6:30am
D
d1wd 7y47jf3t94y
14 Aug 20
$7.5M in options / securities to be acquired, sold $7.5M, 3 investors
5:21pm
4/A
l4t6ofp3nwoghnd7t
7 Aug 20
TherapeuticsMD / James DArecca ownership change
9:16pm
3
avber5q td
7 Aug 20
TherapeuticsMD / EDWARD BORKOWSKI ownership change
9:13pm
3
w7nsr7pw22k8a 5nyt
7 Aug 20
TherapeuticsMD / Marlan D Walker ownership change
9:11pm
S-8
gadokma41lua
7 Aug 20
Registration of securities for employees
5:11pm
8-K
xn9jxwgr3 pd1
6 Aug 20
TherapeuticsMD® Announces Second Quarter 2020 Financial Results
6:56am
8-K
i5fzyx051y0m581zf6zd
23 Jun 20
Regulation FD Disclosure
6:51am